BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3312118)

  • 1. Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
    Beierwaltes WH
    Int J Rad Appl Instrum B; 1987; 14(3):183-9. PubMed ID: 3312118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M; Shinohara S
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract]   [Full Text] [Related]  

  • 3. [Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].
    Horne T
    Harefuah; 1992 Apr; 122(8):526-9. PubMed ID: 1398325
    [No Abstract]   [Full Text] [Related]  

  • 4. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
    Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
    Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
    Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
    Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
    Shapiro B
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
    Fischer M
    Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
    Brendel AJ; Jeandot R; Guyot M; Lambert B; Drouillard J
    Clin Nucl Med; 1989 Jan; 14(1):19-21. PubMed ID: 2714036
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors.
    McEwan AJ; Shapiro B; Sisson JC; Beierwaltes WH; Ackery DM
    Semin Nucl Med; 1985 Apr; 15(2):132-53. PubMed ID: 3890187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-metaiodobenzylguanidine--a new agent for scintigraphic imaging and treatment of pheochromocytoma.
    Fischer M; Vetter W; Winterberg B; Vetter H
    Nuklearmedizin; 1984 Apr; 23(2):77-9. PubMed ID: 6473116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear medicine diagnosis and therapy of distant metastases of pheochromocytoma].
    Grünwald F; Ruhlmann J; Kozak B; Overlack A; Christ F; Hotze A; Biersack HJ
    Dtsch Med Wochenschr; 1988 Feb; 113(8):297-9. PubMed ID: 3277832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
    Troncone L; Rufini V; Montemaggi P; Danza FM; Lasorella A; Mastrangelo R
    Eur J Nucl Med; 1990; 16(4-6):325-35. PubMed ID: 2351179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated iodobenzylguanidines for diagnosis and therapy.
    McEwan AJ; Wyeth P; Ackery D
    Int J Rad Appl Instrum A; 1986; 37(8):765-75. PubMed ID: 3021678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
    Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
    J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.